Endodontic treatment of odontogenic infection in a patient at risk of medication-related osteonecrosis of the jaw: a case report and review of treatment criteria

Gen Dent. 2023 Jul-Aug;71(4):72-76.

Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is an uncommon and severe condition in patients who are receiving treatment with antiresorptive and/or antiangiogenic drugs, which are frequently used to treat or prevent cancer metastases. The treatment of MRONJ is challenging because the choice of a specific dental treatment depends on several factors, including the systemic condition of the patient, type and dosage of medications, and clinical and radiographic characteristics of the dental lesions. This case report describes the conservative endodontic treatment of an odontogenic infection in a patient at risk of developing MRONJ owing to bisphosphonate treatment. Endodontic retreatment was performed to control the odontogenic infection and avoid tooth extraction. Certain factors favor the use of a conservative approach, such as a localized and small infection, the absence of systemic factors (such as metabolic disorders or medications) that can impair bone healing, and good oral hygiene.

Keywords: conservative treatment; dental lesion; endodontic treatment; medication-related osteonecrosis of the jaw; risk awareness.

Publication types

  • Case Reports

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw* / prevention & control
  • Bisphosphonate-Associated Osteonecrosis of the Jaw* / therapy
  • Bone Density Conservation Agents* / adverse effects
  • Dental Care / adverse effects
  • Diphosphonates / adverse effects
  • Humans
  • Tooth Extraction / adverse effects

Substances

  • Bone Density Conservation Agents
  • Diphosphonates